康德萊醫械(01501.HK)上半年純利降24.91%至5060.5萬元
格隆匯8月18日丨康德萊醫械(01501.HK)公佈中期業績,截至2021年6月30日止6個月,公司收入為人民幣1.81億元,同比增長5.10%;毛利為人民幣1.16億元,同比增長1.86%;公司權益股東應占期內利潤為人民幣5060.5萬元,同比下降24.91%;每股盈利為人民幣0.30分。
就按不同產品分類的收入而言,集團於報吿期銷售介入醫療器械產生的收入約為人民幣1.72億元(截至2020年6月30日止六個月期間:人民幣1.17億元),較截至2020年6月30日止六個月期間增加人民幣5501萬元。本集團於報吿期銷售口罩及醫療標準件產生的收入分別約為人民幣35萬元及人民幣492萬元(截至2020年6月30日止六個月期間:人民幣4368萬元及人民幣618萬元)。
集團於報吿期內的研發開支約為人民幣4506萬元,較截至2020年6月30日止六個月期間的約人民幣3022萬元增加約49.11%或約人民幣1484萬元。增加主要是由於集團於報吿期內持續開發及商業化其現有及新管線產品所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.